Sodelglitazar is a pan-PPAR agonist that targets peroxisome proliferator-activated receptors (PPARs), which play a crucial role in lipid metabolism and glucose homeostasis. This compound exhibits significant biological activity in regulating lipid profiles and enhancing insulin sensitivity, making it a promising candidate for the treatment of hyperlipidemia and type 2 diabetes. Research applications include studies focused on metabolic disorders and the exploration of PPAR signaling pathways.
Sodelglitazar is a pan-PPAR agonist that targets peroxisome proliferator-activated receptors (PPARs), which play a crucial role in lipid metabolism and glucose homeostasis. This compound exhibits significant biological activity in regulating lipid profiles and enhancing insulin sensitivity, making it a promising candidate for the treatment of hyperlipidemia and type 2 diabetes. Research applications include studies focused on metabolic disorders and the exploration of PPAR signaling pathways.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
